Literature DB >> 15336275

Multidrug-resistant cancer cell susceptibility to cytotoxic quassinoids, and cancer chemopreventive effects of quassinoids and canthin alkaloids.

Chihiro Murakami1, Narihiko Fukamiya, Sadaaki Tamura, Masayoshi Okano, Kenneth F Bastow, Harukuni Tokuda, Teruo Mukainaka, Hoyoky Nishino, Kuo-Hsiung Lee.   

Abstract

Twenty-three quassinoids (1-23), which were isolated previously from Simaroubaceous plants, were evaluated for cytotoxicity against three multidrug-resistant cancer cell lines, KB-VIN, KB-7d, and KB-CPT. Nine compounds (2-7 and 9-11) showed significant cytotoxicity in all three cell lines. Compounds 1, 12-14, 17, and 20 demonstrated significant activity against the KB-7d and KB-CPT cell lines, and compounds 18, 19, and 23 revealed notable activity only against KB-7d cells. Structure-activity relationships were drawn based on these data. In addition, six quassinoid derivatives (24-29) and four canthin alkaloids (30-33), which were isolated from Brucea antidysenterica, were examined for their inhibitory effects on 12-O-tetradecanoylphorbol-13-acetate (TPA) induced Epstein-Barr virus early antigen (EBV-EA) activation as cancer chemopreventive agents. All of these compounds demonstrated significant inhibitory effects against EBV-EA activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336275     DOI: 10.1016/j.bmc.2004.06.045

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Antitumor Agents. 282. 2'-(R)-O-acetylglaucarubinone, a quassinoid from Odyendyea gabonensis as a potential anti-breast and anti-ovarian cancer agent.

Authors:  Yoshihide Usami; Kyoko Nakagawa-Goto; Jing-Yu Lang; Yoon Kim; Chin-Yu Lai; Masuo Goto; Nobuko Sakurai; Masahiko Taniguchi; Toshiyuki Akiyama; Susan L Morris-Natschke; Kenneth F Bastow; Gordon Cragg; David J Newman; Mihoyo Fujitake; Koichi Takeya; Mien-Chie Hung; Eva Y-H P Lee; Kuo-Hsiung Lee
Journal:  J Nat Prod       Date:  2010-09-24       Impact factor: 4.050

Review 2.  Plant-derived natural product research aimed at new drug discovery.

Authors:  Hideji Itokawa; Susan L Morris-Natschke; Toshiyuki Akiyama; Kuo-Hsiung Lee
Journal:  J Nat Med       Date:  2008-04-22       Impact factor: 2.343

3.  Two new antimalarial quassinoid derivatives from the stems of Brucea javanica.

Authors:  Parinuch Chumkaew; Jaraslak Pechwang; Theera Srisawat
Journal:  J Nat Med       Date:  2017-04-28       Impact factor: 2.343

4.  Bioactivity-guided isolation of cytotoxic constituents of Brucea javanica collected in Vietnam.

Authors:  Li Pan; Young-Won Chin; Hee-Byung Chai; Tran Ngoc Ninh; Djaja Djendoel Soejarto; A Douglas Kinghorn
Journal:  Bioorg Med Chem       Date:  2008-11-05       Impact factor: 3.641

5.  Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  J Med Chem       Date:  2020-12-08       Impact factor: 7.446

6.  Involvement of autophagy inhibition in Brucea javanica oil emulsion-induced colon cancer cell death.

Authors:  Zheng Yan; Bei Zhang; Yuanyuan Huang; Huijuan Qiu; Ping Chen; Gui-Fang Guo
Journal:  Oncol Lett       Date:  2015-01-14       Impact factor: 2.967

7.  Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.

Authors:  Subburayan Karthikeyan; Sugeerappa Laxmanappa Hoti; Yasin Nazeer; Harsha Vasudev Hegde
Journal:  Oncotarget       Date:  2016-07-05

8.  Java brucea and Chinese herbal medicine for the treatment of cholesterol granuloma in the suprasellar and sellar regions: A case report and literature review.

Authors:  Zhe Sun; Yang Cao; Lin-Zhu Zhai
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.